| IL—2／LAK与放,化疗联合治疗晚期恶性肿瘤 |
| |
| 引用本文： | 许素玲 吉军. IL—2／LAK与放,化疗联合治疗晚期恶性肿瘤[J]. 新疆医科大学学报, 2000, 23(1): 41-43 |
| |
| 作者姓名： | 许素玲 吉军 |
| |
| 作者单位： | 附属肿瘤医院肿瘤防治研究所!新疆 乌鲁木齐 830054，附属肿瘤医院肿瘤防治研究所!新疆 乌鲁木齐 830054，附属肿瘤医院肿瘤防治研究所!新疆 乌鲁木齐 830054，附属肿瘤医院肿瘤防治研究所!新疆 乌鲁木齐 830054 |
| |
| 摘 要： | 目的：探讨ＩＬ－／ＬＡＫ细胞与放疗和／或化疗联合治疗晚期恶性肿瘤的价值。方法：本组共３０例，其中单纯ＩＬ－２／ＬＡＫ细胞治疗５例（包括２例ＴＩＬ细胞胸腹腔灌注），ＩＬ－２／ＬＡＫ细胞联合放疗１８例（包括１例动脉灌注），ＩＬ－２／ＬＡＫ细胞联合化疗４例）包括１例动态灌注），ＩＫ－２／ＬＡＫ细胞联合放疗和化疗３例。结果：完全缓解率２０．０％（６／３０），总有效率５０．０％（１５／３９），其中单纯ＩＬ－
|
| 关 键 词： | IL－2／LAK细胞 恶性肿瘤 药物疗法 放射疗法 |
IL-2/LAK cells combination radiotherapy and chemotherapy in the treatmemt of advanced cancer |
| |
| XU Su-ling,JI Jun,LIU Cheng-ming,et al. IL-2/LAK cells combination radiotherapy and chemotherapy in the treatmemt of advanced cancer[J]. Journal of Xinjiang Medical University, 2000, 23(1): 41-43 |
| |
| Authors: | XU Su-ling JI Jun LIU Cheng-ming et al |
| |
| Abstract: | Objective: To evaluate the results of IL-2/LAK cells combination radiotherapy and chemotherapy in the treatment of advanced cancer. Methods: 30 patients of advanced cancer were studied in this trial Of them, 5 patients treated by IL-2/LAK cells alone (2 of 5 patients received TIL cells), 18 patients received IL-2/LAK cells combination radiotherapy (1 of them received artery infusion), 4 patients recei-ved IL-2/ LAK cells combination chemotherapy (1 of them received artery infusion), and 3 patients received IL-2/LAK cells combination radiotherapy and chemotherapy. Results: The overall response rate was 50.0%, (15/30) with a complete response rate of 20.0% (1/5) in IL-2/LAK cells group only, and 56.0% (14/25 ) in combined group. Two patients with Kaposis's sarcoma achieved complete response. Conclusions: This result showed that IL-2/LAK cells for advanced carcinoma are effective, that IL-2/LAK cells combined with radiotherapy and (or) chemotherapy are conducive to good response rate. |
| |
| Keywords: | IL-2/LAK cells radiotherapy chemotherapy combined treatment malignant tumor |
| 本文献已被 CNKI 维普 等数据库收录！ |
